Mark Mossler - Chief Accounting Officer at C4 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Issuer Symbol
CCCC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Mossler since 07 Feb 2025

Holdings reported by Mark Mossler for C4 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18,204 $57,889 $3.18 14 Feb 2025 Direct
Stock Option (Right to Buy) 27,430 14 Feb 2024 Direct Common Stock

Transactions reported by Mark Mossler for C4 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.